Background— Uncertainty remains over optimal antithrombotic treatment of patients with
atrial fibrillation presenting with myocardial infarction and/or undergoing percutaneous …

Objectives : The purpose of this study was to investigate the risk of thrombosis and bleeding
according to multiple antithrombotic treatment regimens in atrial fibrillation (AF) patients after …

Purpose Chronic inflammatory diseases have been linked to increased risk of atherothrombotic
events, but the risk associated with inflammatory bowel disease (IBD) is unclear. We …

Objectives Psoriasis is a chronic inflammatory disorder associated with cardiovascular morbidity
and mortality. Systemic anti‐inflammatory drugs, including biological agents, are widely …

Background Psoriasis is a common disease and is associated with cardiovascular diseases.
Systemic anti‐inflammatory drugs may reduce risk of cardiovascular events. We therefore …

Objectives The purpose of this study was to assess the efficacy and safety of dapagliflozin in
patients taking or not taking an mineralocorticoid receptor antagonist (MRA) at baseline in …

Aims The globalization of clinical trials has highlighted geographic variations in patient
characteristics, event rates, and treatment effects. We investigated these further in PARADIGM-HF…

Background: Both BNP (B-type natriuretic peptide) and NT-proBNP (N-terminal pro B-type
natriuretic peptide) are widely used to aid diagnosis, assess the effect of therapy, and predict …

Aims Inflammation is considered to play a role in the development of atrial fibrillation (AF).
Hence inflammatory bowel disease (IBD) may be associated with AF. We therefore examined …

Heart failure in patients with diabetes has been recognised since 1876. 1 The cardiovascular
harm of thiazolidinediones shone the 21st century spotlight on the interaction between …